首页> 外文期刊>Clinical Psychopharmacology and Neuroscience >The Usefulness and Clinical Characteristics of Antidepressant Use for Stroke Patients with Rehabilitation Program: An Exploratory Analysis
【24h】

The Usefulness and Clinical Characteristics of Antidepressant Use for Stroke Patients with Rehabilitation Program: An Exploratory Analysis

机译:康复计划中风患者抗抑郁用途的有用性和临床特征:探索性分析

获取原文
       

摘要

Objective There has been a lack of data regarding the usefulness and clinical characteristic between patients-treated with and without antidepressants (Pw/Pwo ADs). Methods One hundred and eighty inpatients were recruited and observed for a 6-month. The depressive, cognitive, daily activity, and motor symptoms were evaluated at baseline and tracked at month 6, with the use of rating scales including Beck Depression Inventory (BDI), Mini Mental State Examination (MMSE), Global Deterioration Scale (GDS), modified Rankin Scale (MRS), modified Barthel Index (MBI), and Berg Balance Scale (BBS). Results Among 178 patients, 84 (47.2%) were treated with ADs. PwAD had numerically or significantly higher depressive cognitive, and motor symptoms along with daily activity impairment (8.3 point higher in BDI score, p 0.001; 3.6 point lower in MMSE, p = 0.003; 0.8 point higher in GDS score, p = nonsignificant; 8.2 point lower in BBS score, p = 0.053, and 0.4 point higher in MBI score, p = nonsignificant) than PwoAD. Psychiatric consultation was also significantly higher in PwAD than in PwoAD ( p 0.001). The numbers need to treat for good clinical outcomes between PwAD and PwoAD were 5.8, 6.0, and 7.5, respectively, by MRS, MBI, and BBS scores. Conclusion Our findings suggest the potential utility of AD treatment and different clinical parameters between patients-treated with and without ADs. Adequately-powered and well-controlled further studies are mandatory to confirm and fully elaborate such association.
机译:目的缺乏有关用抗抑郁药治疗患者的有用性和临床特征的数据(PW / PWO ADS)。方法招募了一百八十位住院性,并观察了6个月。在基线评估抑郁,认知,日常活动和电机症状,并在6月6日追踪,使用评级尺度,包括Beck抑郁库存(BDI),迷你精神状态检查(MMSE),全球恶化规模(GDS),改进的Rankin规模(MRS),修改的Barthel指数(MBI)和Berg平衡标度(BBS)。结果178例患者中,用ADS治疗84名(47.2%)。 PWAD在数值或显着提高抑郁的认知和运动症状以及日常活动障碍(BDI评分的8.3点,P <0.001; 3.6点在MMSE中,P = 0.003;在GDS评分中较高0.8点,P =不可思议; 8.2 BBS得分下降,P = 0.053,MBI评分的0.4点,P =不显着)比PWOOD。 PWAD的精神咨询也明显高于PWOAD(P <0.001)。在PWAD和PWOAC之间进行良好临床结果的数字分别是5.8,6.0和7.5,由MRS,MBI和BBS分别分别进行。结论我们的研究结果表明AD治疗的潜在效用以及患者治疗患者的不同临床参数。有充分的动力和受控进一步的进一步研究是必须确认和完全详细阐述这种关联的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号